Holding Your Own: Who Really Owns the Patient When an Associate Leaves?
Jay A. Shorr, BA, MBM-C, CAC I-VIII gives advice on who "owns" the patient once an associate leaves, in the January 2016 issue's "The Shorr Thing."
Jay A. Shorr, BA, MBM-C, CAC I-VIII gives advice on who "owns" the patient once an associate leaves, in the January 2016 issue's "The Shorr Thing."
A noninvasive molecular test identifies patients more likely to respond to JAK inhibitors versus Th2-targeted therapies, potentially accelerating clearance and reducing treatment switches.